WORX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
WORX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
SCWorx's Capital Expenditure for the three months ended in Sep. 2024 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2024 was $0.76 Mil.
Hence, SCWorx's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.00.
The historical data trend for SCWorx's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SCWorx Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Capex-to-Revenue | Get a 7-Day Free Trial | 0.02 | - | - | - | - |
SCWorx Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Capex-to-Revenue | Get a 7-Day Free Trial | - | - | - | - | - |
For the Health Information Services subindustry, SCWorx's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, SCWorx's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where SCWorx's Capex-to-Revenue falls into.
SCWorx's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (0) | / | 3.805 | |
= | 0.00 |
SCWorx's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (0) | / | 0.76 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SCWorx (NAS:WORX) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Thank you for viewing the detailed overview of SCWorx's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Vincent Michael Matozzo | director | 412 RICHARD LANE, ORANGE CT 06477 |
Christopher John Kohler | officer: Chief Financial Officer | 1149 CANTERBERRY LN, PARKER CO 80138 |
Steven Wallitt | director | C/O SCWORX CORP., 590 MADISON AVENUE, 21ST FLOOR, NEW YORK NY 10022 |
John C Ferrara | director | C/O EDGAR ONLINE, INC., 50 WASHINGTON STREET, NORWALK CT 06854 |
Steven Ross Horowitz | director | 4 MELISSA COURT, MONTVILLE NJ 07045 |
Marc Sanford Schessel | director, 10 percent owner, officer: CEO | 4 JACOBS LANE, NEW PALTZ NY 12561 |
Irby Alton F Iii | director | C/O MCKESSON CORP, ONE POST ST., SAN FRANCISCO CA 94104 |
Miller Charles Kenneth Iii | director | 100 METROPLEX, EDISON NJ 08817 |
Timothy Andrew Hannibal | officer: President, COO | 590 MADISON AVE, NEW YORK NY 10022 |
Mark Shefts | director | 160 SUMMIT AVE, MONTVALE NJ 07645 |
John C Price | other: Former CFO | 4721 IRONTON STREET, BUILDING A, DENVER CO 80239 |
Robert Steven Christie | director | 34 SAN MARCO STREET, WEST WINDSOR NJ 08550 |
Ira E. Ritter | director | C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096 |
Knuettel Ii Francis | director | 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701 |
James Thaddeus Schweikert | officer: Chief Operating Officer | 7783 SOARING EAGLE CT., CINCINNATI OH 45244 |
From GuruFocus
By Value_Insider Value_Insider • 12-13-2022
By GuruFocusNews GuruFocusNews • 07-06-2022
By Marketwired • 04-23-2024
By Marketwired Marketwired • 09-23-2021
By GlobeNewswire GlobeNewswire • 07-05-2022
By Marketwired • 11-20-2024
By Ds*** Ds*** • 08-30-2022
By Stock market mentor Stock market mentor • 01-30-2023
By sperokesalga sperokesalga • 04-25-2023
By GuruFocusNews GuruFocusNews • 02-02-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.